Guangzhou Baiy | 600332 - Ebit

Aktienkurs
22.76
Täglich Wechseln
-0.27 -1.17%
Monatlich
-9.57%
Jährlich
-12.02%
Q2 Prognose
22.49




Ebit Veränderung Datum
Aspen Pharmacare ZAR 3.76B 1.04B 2025-12
Cipla INR 9.77B 6.21B 2025-12
Dr.Reddys Laboratories INR 13.94B 1.79B 2025-12
Jiangsu Hengrui CNY 2.25B 848.02M 2025-12
Kalbe Farma IDR 851.77B 342.14B 2025-09
Richter Gedeon HUF 63.58B 6.08B 2025-09
Sh Fosun Pharma CNY 864.14M 185.2M 2025-12
Sh Pharmaceutical CNY 1.88B 283.52M 2025-12
Sun Pharmaceuticals INR 40.62B 6.95B 2025-12
Teva Pharmaceutical Industries USD 577M 491M 2025-12